Edwards Lifesciences | EW - 净收入



金融业
股票价格
USD
资产
USD 13.32B
现金及等价物
USD 2.4B
销售成本
USD 362.6M
流动资产
USD 6.23B
流动负债
USD 1.41B
债务
USD 600M
EBIT
USD 514.7M
EBITDA
USD 70.1M
员工
15.8K
EPS每股收益
USD 0.78
股本和储备
USD 10.33B
销售毛利
USD 1.29B
债务利息支出
USD 35.9M
利息收入
USD 56.3M
贷款资金
USD 600M
市值
USD 51.52B
净收入
USD 380.7M
营业费用
USD 1.13B
营业利润
USD 514.7M
普通股股本
USD 580.7M
PE价格收益
26.87
税前利润
USD 348.4M
销售收入
USD 1.65B
销售和管理费用
USD 522.2M
股票
USD 1.12B
贸易债权人
USD 181.1M
应收帐款人
USD 912.1M


净收入 更改 日
Abbott USD 1.08B 699M 2026-03
Artivion USD 2.42M 4.07M 2025-12
AtriCure USD 108K 1.65M 2026-03
Baxter International USD -15M 1.11B 2026-03
Becton, Dickinson and Co. USD -311M 693M 2026-03
Boston Scientific USD 1.34B 669M 2026-03
Cooper Companies USD -77.9M 208.7M 2026-03
Dexcom USD 199.5M 67.8M 2026-03
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Globus Medical USD 140.59M 21.63M 2025-12
ICU Medical USD -15.73M 12.34M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 91.1M 10.5M 2026-03
Integra LifeSciences USD -4.62M 2.91M 2026-03
Intuitive Surgical USD 821.5M 26.7M 2026-03
J&J USD 5.24B 119M 2026-03
Medtronic USD 1.24B 100M 2026-03
Merit Medical Systems USD 41M 2.99M 2026-03
Stryker USD 745M 104M 2026-03
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -8.15M 706.18M 2026-03
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03